{
    "clinical_study": {
        "@rank": "16845", 
        "brief_summary": {
            "textblock": "Subjects are healthy adult volunteers either at high risk for HIV infection or already known\n      to be seropositive, who will donate blood for in vitro tests of T-cell function and in vitro\n      responses to synthetic peptides corresponding to sequences from HIV proteins."
        }, 
        "brief_title": "Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines", 
        "completion_date": "September 2000", 
        "condition": [
            "HIV Infections", 
            "Healthy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Subjects are healthy adult volunteers either at high risk for HIV infection or already known\n      to be seropositive, who will donate blood for in vitro tests of T-cell function and in vitro\n      responses to synthetic peptides corresponding to sequences from HIV proteins."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria for the at risk group will be a statement from the donor that he is an\n        active homosexual or bisexual.\n\n        Homosexual donors must not have AIDS."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "60", 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001210", 
            "org_study_id": "860199", 
            "secondary_id": "86-C-0199"
        }, 
        "keyword": [
            "Blood Donors", 
            "Epitopes", 
            "HIV"
        ], 
        "lastchanged_date": "March 3, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Cancer Institute (NCI)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "2524668", 
                "citation": "Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, Shearer GM, Berzofsky JA. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature. 1989 Jun 1;339(6223):383-5."
            }, 
            {
                "PMID": "7903123", 
                "citation": "Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993 Dec 10;262(5140):1721-4."
            }, 
            {
                "PMID": "7635981", 
                "citation": "Pinto LA, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, Shearer GM. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest. 1995 Aug;96(2):867-76."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001210"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "November 1986", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "October 1999"
    }, 
    "geocoordinates": {
        "National Cancer Institute (NCI)": "38.985 -77.095"
    }
}